Drugs / Deuterated nicotine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01058876 | Dec 2009 → Jan 2013 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1 | NCT00879918 | Dec 2008 → Mar 2012 | — | University of California, San Francisco | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Deuterated nicotine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01058876 ↗ |
| Route | Intravenous | “after IV dosing” NCT00879918 ↗ |